Ductal adenocarcinoma of the pancreas: Expression of growth factor receptors, oncogenes and suppressor genes, and their relationship to pathological features, staging and survival.

@article{LozanoLen2011DuctalAO,
  title={Ductal adenocarcinoma of the pancreas: Expression of growth factor receptors, oncogenes and suppressor genes, and their relationship to pathological features, staging and survival.},
  author={Antonio Lozano-Le{\'o}n and Bego{\~n}a Vieites P{\'e}rez-Quintela and Julio Iglesias-Garc{\'i}a and Jos{\'e} Lari{\~n}o-Noia and Evaristo Var{\'o} and Jer{\'o}nimo Forteza and Juan Enrique Dom{\'i}nguez-Mu{\~n}oz},
  journal={Oncology letters},
  year={2011},
  volume={2 1},
  pages={161-166}
}
Pancreatic ductal adenocarcinoma results in high short-term mortality despite recent advances in diagnostics, surgery and chemotherapy. Modern chemotherapeutic agents directed to specific tumor receptors have higher therapeutic efficacy and lower adverse effects. However, few studies exist that evaluate the clinical impact in pancreatic cancer. The expression of tumor growth factor receptors, oncogenes and tumor suppressor oncogenes in surgical pancreatic cancer specimens as related to… CONTINUE READING